Results of 25 years of treatment of phaeochromocytoma in Groningen University Hospital;Resultaten van 25 jaar feochromocytoombehandeling in het Academisch Ziekenhuis Groningen

Nederlands Tijdschrift voor Geneeskunde

Volumn 141, Issue 3, 1997, Pages 148-151

  De Graak, J S ^a  

^a Divisie Klinische Farmacologie   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGRAPHY; ARTICLE; CANCER LOCALIZATION; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; TREATMENT OUTCOME; ULTRASOUND;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADULT; AGED; DIAGNOSTIC IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PHEOCHROMOCYTOMA; RETROSPECTIVE STUDIES;

EID: 0031040060     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Karet FE. Brown MJ. Phaeochromocyloma: diagnosis and management. Postgrad Med J 1994:70:326-8.
2. Shapiro B. Fig LM. Management of phcochromocytoma. Endocrinol Metah Clin North Am 1(189:18:443-81.
3. Lips KJM. Sluys Veer J van der, Struyvenberg A, Alleman A, Leo JR. Wittebol P. et al. Bilateral occurence of pheochromocytoma in patienls with the multiple endocrine neoplasia syndrome type 2A (Sipple's syndrome). Am J Med 1981:70:1051-60.
4. Modigliani E. Vasen HM, Raue K, Dralle H. Frilling A, Gheri RG. et al. Pheochromoeyloma in multiple endocrine neoplasia type 2: European study. The Euromen Study Group. J Intern Med 1995: 238:363-7.
5. Shapiro B. Imaging ol catecholamine-secreting tumours: uses of MIBG in diagnosis and treatment. Baillieres Clin Endocrinol Metab 1993:7:491-507.
6. Ciraaf JS de, Klooster NJJ, Lange WE de. Piers DA. Zwierstra RP. Vergelijking van jodium-scintigrafie en computertomografie bij de lokalisatie van het feochromocytoom. Ned Tijdschr Geneeskd 1991:135:2383-7.
7. Brennan MF. Reiser HR. Persistent and recurrent pheochromocytoma: the role of surgery. \Vorld J Surg 1982:6:397-402.
8. Cheung PS. Thompson NW, Dmuchowski CF. Sisson JC. Spectrum of pheochromocytoma in the i3iI-MIBG era. World J Surg 1988; 12:546-51.
9. Chalal JF. Charbonnel B. Comparison of iodobenzylguamdine imaging with computed tomography in locating pheochromocytoma. Clin Endocrinol Metab 1985:61:769-72.
10. McEwan AJ. Shapiro B. Sisson JC. Beierwaltes WH, Ackery DM. Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumors. Semin Nucl Med 1985:15:132-53.
11. Clesham CM, Kennedy A, Lavender JP, Dollery CT, Wilkins MR. Meta-iodobenzylguanidine (MIBG) scanning in the diagnosis of phaeochromocytoma. J Human Hvpertens 1991:7:353-6.
12. Laursen K. Damgaard-Pedersen K. CT for pheochromocytoma diagnosis. J Comput Assist Tomogr 1984:8:895-9: AJR 1980:134:27780.
13. Moullon JS. Moulton JS. CT of the adrenal glands. Semin Roentgenol 1988:23:288-303.
14. Korobkin M. Broduer FJ, Yutzy GG, Francis IR, Quint LE, Dunnick NR. et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR 1996:166:531-6.
15. Falke TH. Gils AP van. Seters AP. Sandler MP. Magnetic resonance imaging of functioning paragangliomas. Magn Reson Q 1990:6:35-64.
16. Reinig JW. Stutley JE, Leonhardt CM, Spicer KM, Margohs M. Caldwell CB. Differentiation of adrenal masses with MR imaging: comparison of techniques. Radiology 1994:192:41-6.
17. Samaan NA. Hickey RC. Shutts PE. Diagnosis, localization, and management of pheochromocytoma. Pitfalls and follow-up in 41 patienls. C'ancer 1988:62:2411-60.
18. Irvin GL 3d, Fishman LM. Shcr JA. Yeung LK. Irani H. Pheochromocytoma. Lateral versus anterior operative approach. Ann Surg 1989:209:774-8.
19. Fahey TJ 3rd. Reeve TS, Delhridge L. Adrenalectomy: expanded indications for the extraperitoneal approach. Aust N Z J Surg 1994: 64:494-7.
20. Orchard T, Grant CS. Heerden JA van. Weaver A. Pheochromocyloma - continuing evolution of surgical therapy. Surgery 1993: 114:1153-9.
21. Obara T, Kanbe M. Okamoto T, Ito Y, Yamashita T, Ito K. et al. Surgical strategy for pheochromocytoma: emphasis on the pledge of flank exlraperitoneal approach in selected patients. Surgery 1995: 118:1083-9.
22. Tihblin S, Dymling JF, Ingemansson S, Telenius-Berg M. Unilateral versus bilateral adrenalectomy in multiple endocrine neoplasia IIA. World J Surg 1983:7:201-8.
23. Beatty OL. Russell CFJ. Kennedy L, Madden DR. Kennedy TL. Atkinson AB. Phaeochromocytoma in Northern Ireland: a 21 year review. Eur J Surg 1996:162:695-702.
24. Jansson S. Tisell LE. Fjälling M, Lindberg S. Jacobsson L, Zachrisson BF. Early diagnosis of and surgical strategy for adrenal medullary disease in MEN II gene carriers. Surgery 1988:103:11-8.
25. Lairmorc TC. Ball DW. Baylin SB, Wells SA jr. Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes. Ann Surg 1993:217:595-603.
26. Heerden JA van, Sizemore GW. Carney JA. Grant CS, ReMine WH. Sheps SG. Surgical management of the adrenal glands in the multiple endocrine neoplasia type II syndrome. World J Surg 1984: 8:612-21.
27. Evans DB. Lee .IE. Merrell RC, Hickey RC. Adrenal medullary disease in mutiple endocrine neoplasia type 2. Appropriate management. Endocrinol Metab Clin North Am 1994:23:167-76.
28. Telenius-Berg M. Ponder MA. Berg B, Ponder BA. Werner S. Quality of life after bilateral adrenalectomy in MEN 2. Henry Ford Hosp Med J 1989:37:160-3.